Literature DB >> 25389225

Commentary on Vickers.

Michael S Lauer1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25389225      PMCID: PMC4232225          DOI: 10.1177/1740774514553482

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  16 in total

1.  Transforming the scientific, health care, and sociopolitical culture of an entire country through clinical research: the story of GISSI.

Authors:  Salim Yusuf
Journal:  Am Heart J       Date:  2004-08       Impact factor: 4.749

2.  Participation versus education: the GISSI story and beyond.

Authors:  Luigi Tavazzi; Aldo P Maggioni; Gianni Tognoni
Journal:  Am Heart J       Date:  2004-08       Impact factor: 4.749

3.  Scientific evidence underlying the ACC/AHA clinical practice guidelines.

Authors:  Pierluigi Tricoci; Joseph M Allen; Judith M Kramer; Robert M Califf; Sidney C Smith
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

4.  Medicine. A bruising battle over lung scans.

Authors:  Eliot Marshall
Journal:  Science       Date:  2008-05-02       Impact factor: 47.728

5.  Patient organizations and research on rare diseases.

Authors:  Julie R Ingelfinger; Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

6.  Commentary: Will academia embrace comparative effectiveness research?

Authors:  Michael S Lauer
Journal:  Acad Med       Date:  2011-06       Impact factor: 6.893

7.  Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being.

Authors:  Elliott M Antman; Robert A Harrington
Journal:  JAMA       Date:  2012-11-07       Impact factor: 56.272

8.  Network news: powering clinical research.

Authors:  Joseph V Selby; Harlan M Krumholz; Richard E Kuntz; Francis S Collins
Journal:  Sci Transl Med       Date:  2013-04-23       Impact factor: 17.956

9.  Clinical trials in crisis: Four simple methodologic fixes.

Authors:  Andrew J Vickers
Journal:  Clin Trials       Date:  2014-10-01       Impact factor: 2.486

10.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.